Sensorineural hearing impairment was found in 62.5% of OPA1 mutation carriers and was the second most common main clinical characteristic in ADOA-plus patients among the extraocular diseases, other than optic neuropathy brought on by OPA1 gene mutations. This evidence concerns the gene OPA1 and Optic neuropathy.